Encompass Health Corporation (NYSE: EHC) Stock Competitors & Peer Comparison
See EHC's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for EHC and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EHC | $112.89 | +1.65% | 11.2B | 19.83 | $5.69 | +0.67% |
| HCA | $382.19 | +1.51% | 84.8B | 13.20 | $28.96 | +0.78% |
| THC | $233.20 | +17.17% | 20.1B | 13.53 | $17.24 | N/A |
| DVA | $235.44 | +0.50% | 15.1B | 20.06 | $11.73 | N/A |
| SOLV | $78.01 | +1.00% | 13.5B | 12.50 | $6.24 | N/A |
| FMS | $24.59 | +0.61% | 13.2B | 9.76 | $2.52 | +3.52% |
| ENSG | $172.99 | +3.27% | 10.1B | 25.07 | $6.90 | +0.15% |
| UHS | $155.75 | +2.96% | 9.8B | 6.91 | $22.54 | +0.51% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $46.85 | +4.53% | 7.4B | 39.80 | $1.18 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
EHC vs HCA Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, HCA has a market cap of 84.8B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while HCA trades at $382.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas HCA's P/E ratio is 13.20. In terms of profitability, EHC's ROE is +0.25%, compared to HCA's ROE of -1.54%. Regarding short-term risk, EHC is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
EHC vs THC Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, THC has a market cap of 20.1B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while THC trades at $233.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas THC's P/E ratio is 13.53. In terms of profitability, EHC's ROE is +0.25%, compared to THC's ROE of +0.38%. Regarding short-term risk, EHC is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for EHC.Check THC's competition here
DaVita Inc. (NYSE: DVA)
EHC vs DVA Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, DVA has a market cap of 15.1B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while DVA trades at $235.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas DVA's P/E ratio is 20.06. In terms of profitability, EHC's ROE is +0.25%, compared to DVA's ROE of -1.33%. Regarding short-term risk, EHC is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for EHC.Check DVA's competition here
Solventum Corporation (NYSE: SOLV)
EHC vs SOLV Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, SOLV has a market cap of 13.5B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while SOLV trades at $78.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas SOLV's P/E ratio is 12.50. In terms of profitability, EHC's ROE is +0.25%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, EHC is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for EHC.Check SOLV's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
EHC vs FMS Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, FMS has a market cap of 13.2B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while FMS trades at $24.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas FMS's P/E ratio is 9.76. In terms of profitability, EHC's ROE is +0.25%, compared to FMS's ROE of +0.07%. Regarding short-term risk, EHC is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for EHC.Check FMS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
EHC vs ENSG Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, ENSG has a market cap of 10.1B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while ENSG trades at $172.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas ENSG's P/E ratio is 25.07. In terms of profitability, EHC's ROE is +0.25%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, EHC is less volatile compared to ENSG. This indicates lower risk in terms of short-term price fluctuations for EHC.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
EHC vs UHS Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, UHS has a market cap of 9.8B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while UHS trades at $155.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas UHS's P/E ratio is 6.91. In terms of profitability, EHC's ROE is +0.25%, compared to UHS's ROE of +0.21%. Regarding short-term risk, EHC is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
EHC vs OSH Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas OSH's P/E ratio is -17.65. In terms of profitability, EHC's ROE is +0.25%, compared to OSH's ROE of +4.64%. Regarding short-term risk, EHC is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for EHC.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
EHC vs PACS Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, PACS has a market cap of 7.4B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while PACS trades at $46.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas PACS's P/E ratio is 39.80. In terms of profitability, EHC's ROE is +0.25%, compared to PACS's ROE of +0.27%. Regarding short-term risk, EHC is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
EHC vs CHE Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while CHE trades at $511.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas CHE's P/E ratio is 23.66. In terms of profitability, EHC's ROE is +0.25%, compared to CHE's ROE of +0.25%. Regarding short-term risk, EHC is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for EHC.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
EHC vs LHCG Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas LHCG's P/E ratio is 82.83. In terms of profitability, EHC's ROE is +0.25%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, EHC is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for EHC.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
EHC vs LFST Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, LFST has a market cap of 4.2B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while LFST trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas LFST's P/E ratio is 173.65. In terms of profitability, EHC's ROE is +0.25%, compared to LFST's ROE of +0.02%. Regarding short-term risk, EHC is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for EHC.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
EHC vs CON Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, CON has a market cap of 4B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while CON trades at $31.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas CON's P/E ratio is 21.95. In terms of profitability, EHC's ROE is +0.25%, compared to CON's ROE of +0.46%. Regarding short-term risk, EHC is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for EHC.Check CON's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
EHC vs BKD Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, BKD has a market cap of 3.6B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while BKD trades at $15.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas BKD's P/E ratio is -26.11. In terms of profitability, EHC's ROE is +0.25%, compared to BKD's ROE of +401.19%. Regarding short-term risk, EHC is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for EHC.Check BKD's competition here
National HealthCare Corporation (AMEX: NHC)
EHC vs NHC Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while NHC trades at $225.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas NHC's P/E ratio is 32.32. In terms of profitability, EHC's ROE is +0.25%, compared to NHC's ROE of +0.12%. Regarding short-term risk, EHC is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for EHC.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
EHC vs OPCH Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, OPCH has a market cap of 3.4B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while OPCH trades at $21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas OPCH's P/E ratio is 12.59. In terms of profitability, EHC's ROE is +0.25%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, EHC is less volatile compared to OPCH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
EHC vs AMED Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas AMED's P/E ratio is 39.30. In terms of profitability, EHC's ROE is +0.25%, compared to AMED's ROE of +0.11%. Regarding short-term risk, EHC is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for EHC.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
EHC vs ACHC Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, ACHC has a market cap of 3.2B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while ACHC trades at $34.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas ACHC's P/E ratio is 17.34. In terms of profitability, EHC's ROE is +0.25%, compared to ACHC's ROE of -0.44%. Regarding short-term risk, EHC is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for EHC.Check ACHC's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
EHC vs MD Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while MD trades at $26.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas MD's P/E ratio is 12.27. In terms of profitability, EHC's ROE is +0.25%, compared to MD's ROE of +0.20%. Regarding short-term risk, EHC is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for EHC.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
EHC vs ADUS Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, ADUS has a market cap of 2.1B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while ADUS trades at $114.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas ADUS's P/E ratio is 17.79. In terms of profitability, EHC's ROE is +0.25%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, EHC is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for EHC.Check ADUS's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
EHC vs AVAH Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, AVAH has a market cap of 2.1B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while AVAH trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas AVAH's P/E ratio is 13.90. In terms of profitability, EHC's ROE is +0.25%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, EHC is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AVAH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
EHC vs SGRY Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, SGRY has a market cap of 2.1B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while SGRY trades at $15.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas SGRY's P/E ratio is 40.33. In terms of profitability, EHC's ROE is +0.25%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, EHC is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for EHC.Check SGRY's competition here
Select Medical Holdings Corporation (NYSE: SEM)
EHC vs SEM Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas SEM's P/E ratio is 15.43. In terms of profitability, EHC's ROE is +0.25%, compared to SEM's ROE of +0.08%. Regarding short-term risk, EHC is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for EHC.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
EHC vs ASTH Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, ASTH has a market cap of 2B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while ASTH trades at $40.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas ASTH's P/E ratio is 27.24. In terms of profitability, EHC's ROE is +0.25%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, EHC is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check ASTH's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
EHC vs AMEH Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas AMEH's P/E ratio is 39.25. In terms of profitability, EHC's ROE is +0.25%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, EHC is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AMEH's competition here
Agilon Health, Inc. (NYSE: AGL)
EHC vs AGL Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while AGL trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas AGL's P/E ratio is -9.57. In terms of profitability, EHC's ROE is +0.25%, compared to AGL's ROE of -1.46%. Regarding short-term risk, EHC is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
EHC vs INNV Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, INNV has a market cap of 1.6B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while INNV trades at $11.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas INNV's P/E ratio is -128.44. In terms of profitability, EHC's ROE is +0.25%, compared to INNV's ROE of -0.09%. Regarding short-term risk, EHC is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for EHC.Check INNV's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
EHC vs HCSG Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while HCSG trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas HCSG's P/E ratio is 18.19. In terms of profitability, EHC's ROE is +0.25%, compared to HCSG's ROE of +0.23%. Regarding short-term risk, EHC is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for EHC.Check HCSG's competition here
Ardent Health Inc. (NYSE: ARDT)
EHC vs ARDT Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, ARDT has a market cap of 1.5B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while ARDT trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas ARDT's P/E ratio is 6.47. In terms of profitability, EHC's ROE is +0.25%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, EHC is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for EHC.Check ARDT's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
EHC vs PNTG Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while PNTG trades at $41.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas PNTG's P/E ratio is 33.46. In terms of profitability, EHC's ROE is +0.25%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, EHC is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for EHC.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
EHC vs AMN Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while AMN trades at $32.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas AMN's P/E ratio is 10.93. In terms of profitability, EHC's ROE is +0.25%, compared to AMN's ROE of -0.05%. Regarding short-term risk, EHC is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
EHC vs BKDT Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas BKDT's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, EHC is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for EHC.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
EHC vs USPH Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, USPH has a market cap of 1.1B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while USPH trades at $74.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas USPH's P/E ratio is 28.74. In terms of profitability, EHC's ROE is +0.25%, compared to USPH's ROE of +0.00%. Regarding short-term risk, EHC is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for EHC.Check USPH's competition here
COMPASS Pathways plc (NASDAQ: CMPS)
EHC vs CMPS Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, CMPS has a market cap of 1.1B. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while CMPS trades at $11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas CMPS's P/E ratio is -5.49. In terms of profitability, EHC's ROE is +0.25%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, EHC is less volatile compared to CMPS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CMPS's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
EHC vs FSHCX Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, FSHCX has a market cap of 882M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while FSHCX trades at $120.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas FSHCX's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to FSHCX's ROE of N/A. Regarding short-term risk, EHC is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for EHC.Check FSHCX's competition here
Talkspace, Inc. (NASDAQ: TALKW)
EHC vs TALKW Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, TALKW has a market cap of 874.4M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas TALKW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, EHC is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check TALKW's competition here
Talkspace, Inc. (NASDAQ: TALK)
EHC vs TALK Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, TALK has a market cap of 872.7M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while TALK trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas TALK's P/E ratio is 768.44. In terms of profitability, EHC's ROE is +0.25%, compared to TALK's ROE of +0.01%. Regarding short-term risk, EHC is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for EHC.Check TALK's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
EHC vs NUTX Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, NUTX has a market cap of 868.6M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while NUTX trades at $145.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas NUTX's P/E ratio is 11.27. In terms of profitability, EHC's ROE is +0.25%, compared to NUTX's ROE of +0.31%. Regarding short-term risk, EHC is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for EHC.Check NUTX's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
EHC vs SNDA Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, SNDA has a market cap of 833.8M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while SNDA trades at $41.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas SNDA's P/E ratio is -7.72. In terms of profitability, EHC's ROE is +0.25%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, EHC is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for EHC.Check SNDA's competition here
Enhabit, Inc. (NYSE: EHAB)
EHC vs EHAB Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas EHAB's P/E ratio is -197.14. In terms of profitability, EHC's ROE is +0.25%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, EHC is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for EHC.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
EHC vs GMRS Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, GMRS has a market cap of 594M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while GMRS trades at $12.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas GMRS's P/E ratio is 5.76. In terms of profitability, EHC's ROE is +0.25%, compared to GMRS's ROE of +1.01%. Regarding short-term risk, EHC is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
EHC vs TOI Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, TOI has a market cap of 497.9M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while TOI trades at $4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas TOI's P/E ratio is -13.83. In terms of profitability, EHC's ROE is +0.25%, compared to TOI's ROE of +3.27%. Regarding short-term risk, EHC is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for EHC.Check TOI's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
EHC vs VMD Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, VMD has a market cap of 451.2M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while VMD trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas VMD's P/E ratio is 31.81. In terms of profitability, EHC's ROE is +0.25%, compared to VMD's ROE of +0.11%. Regarding short-term risk, EHC is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for EHC.Check VMD's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
EHC vs MCTA Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas MCTA's P/E ratio is 419.36. In terms of profitability, EHC's ROE is +0.25%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, EHC is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for EHC.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
EHC vs SRTA Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, SRTA has a market cap of 436.1M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while SRTA trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas SRTA's P/E ratio is -35.46. In terms of profitability, EHC's ROE is +0.25%, compared to SRTA's ROE of +0.18%. Regarding short-term risk, EHC is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check SRTA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
EHC vs TOIIW Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, TOIIW has a market cap of 388.9M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas TOIIW's P/E ratio is -0.18. In terms of profitability, EHC's ROE is +0.25%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, EHC is less volatile compared to TOIIW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check TOIIW's competition here
Community Health Systems, Inc. (NYSE: CYH)
EHC vs CYH Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, CYH has a market cap of 384M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while CYH trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas CYH's P/E ratio is 3.73. In terms of profitability, EHC's ROE is +0.25%, compared to CYH's ROE of +0.21%. Regarding short-term risk, EHC is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
EHC vs AUNA Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, AUNA has a market cap of 373.8M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while AUNA trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas AUNA's P/E ratio is 4.55. In terms of profitability, EHC's ROE is +0.25%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, EHC is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AUNA's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
EHC vs AIRS Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, AIRS has a market cap of 325.2M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while AIRS trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas AIRS's P/E ratio is -153.67. In terms of profitability, EHC's ROE is +0.25%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, EHC is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
EHC vs CSU Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas CSU's P/E ratio is 0.67. In terms of profitability, EHC's ROE is +0.25%, compared to CSU's ROE of -0.51%. Regarding short-term risk, EHC is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
EHC vs JYNT Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, JYNT has a market cap of 119M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while JYNT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas JYNT's P/E ratio is 83.50. In terms of profitability, EHC's ROE is +0.25%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, EHC is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for EHC.Check JYNT's competition here
biote Corp. (NASDAQ: BTMD)
EHC vs BTMD Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, BTMD has a market cap of 100.6M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while BTMD trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas BTMD's P/E ratio is 5.18. In terms of profitability, EHC's ROE is +0.25%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, EHC is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for EHC.Check BTMD's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
EHC vs FVE Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas FVE's P/E ratio is -5.64. In terms of profitability, EHC's ROE is +0.25%, compared to FVE's ROE of -0.15%. Regarding short-term risk, EHC is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for EHC.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
EHC vs KDLYW Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas KDLYW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, EHC is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check KDLYW's competition here
DocGo Inc. (NASDAQ: DCGO)
EHC vs DCGO Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, DCGO has a market cap of 58.9M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while DCGO trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas DCGO's P/E ratio is -0.68. In terms of profitability, EHC's ROE is +0.25%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, EHC is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for EHC.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
EHC vs ALR Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas ALR's P/E ratio is -1.11. In terms of profitability, EHC's ROE is +0.25%, compared to ALR's ROE of -0.15%. Regarding short-term risk, EHC is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for EHC.Check ALR's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
EHC vs PARK Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, PARK has a market cap of 36.5M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while PARK trades at $18.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas PARK's P/E ratio is 25.36. In terms of profitability, EHC's ROE is +0.25%, compared to PARK's ROE of -0.24%. Regarding short-term risk, EHC is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for EHC.Check PARK's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
EHC vs IMAC Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas IMAC's P/E ratio is -2.27. In terms of profitability, EHC's ROE is +0.25%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, EHC is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for EHC.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
EHC vs PIII Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, PIII has a market cap of 31.5M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while PIII trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas PIII's P/E ratio is -0.24. In terms of profitability, EHC's ROE is +0.25%, compared to PIII's ROE of +1.85%. Regarding short-term risk, EHC is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for EHC.Check PIII's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
EHC vs CCEL Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, CCEL has a market cap of 28.1M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while CCEL trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas CCEL's P/E ratio is -10.55. In terms of profitability, EHC's ROE is +0.25%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, EHC is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CCEL's competition here
Cano Health, Inc. (NYSE: CANO-WT)
EHC vs CANO-WT Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, EHC is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
EHC vs AIH Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas AIH's P/E ratio is -2.78. In terms of profitability, EHC's ROE is +0.25%, compared to AIH's ROE of +1.16%. Regarding short-term risk, EHC is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
EHC vs CANO Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas CANO's P/E ratio is -0.01. In terms of profitability, EHC's ROE is +0.25%, compared to CANO's ROE of -1.49%. Regarding short-term risk, EHC is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
EHC vs FPCG Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas FPCG's P/E ratio is 0.09. In terms of profitability, EHC's ROE is +0.25%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, EHC is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for EHC.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
EHC vs FTRP Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas FTRP's P/E ratio is -1.22. In terms of profitability, EHC's ROE is +0.25%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, EHC is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for EHC.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
EHC vs AMS Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while AMS trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas AMS's P/E ratio is -6.47. In terms of profitability, EHC's ROE is +0.25%, compared to AMS's ROE of -0.06%. Regarding short-term risk, EHC is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
EHC vs BMGL Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, BMGL has a market cap of 9.2M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while BMGL trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas BMGL's P/E ratio is -1.11. In terms of profitability, EHC's ROE is +0.25%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, EHC is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for EHC.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
EHC vs XWEL Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, XWEL has a market cap of 6.4M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while XWEL trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas XWEL's P/E ratio is -0.32. In terms of profitability, EHC's ROE is +0.25%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, EHC is less volatile compared to XWEL. This indicates lower risk in terms of short-term price fluctuations for EHC.Check XWEL's competition here
ModivCare Inc. (NASDAQ: MODV)
EHC vs MODV Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas MODV's P/E ratio is -0.06. In terms of profitability, EHC's ROE is +0.25%, compared to MODV's ROE of +1.36%. Regarding short-term risk, EHC is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for EHC.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
EHC vs GBNH Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas GBNH's P/E ratio is -0.06. In terms of profitability, EHC's ROE is +0.25%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, EHC is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
EHC vs RHE-PA Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, EHC's ROE is +0.25%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, EHC is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
EHC vs RHE Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas RHE's P/E ratio is -1.79. In terms of profitability, EHC's ROE is +0.25%, compared to RHE's ROE of -0.36%. Regarding short-term risk, EHC is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for EHC.Check RHE's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
EHC vs AIDX Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, AIDX has a market cap of 2.8M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while AIDX trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas AIDX's P/E ratio is -0.93. In terms of profitability, EHC's ROE is +0.25%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, EHC is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for EHC.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
EHC vs IMACW Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas IMACW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, EHC is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
EHC vs NAKAW Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, EHC's ROE is +0.25%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, EHC is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for EHC.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
EHC vs CCM Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, CCM has a market cap of 626.1K. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while CCM trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas CCM's P/E ratio is -0.29. In terms of profitability, EHC's ROE is +0.25%, compared to CCM's ROE of +0.06%. Regarding short-term risk, EHC is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
EHC vs NIVF Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, NIVF has a market cap of 212.3K. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while NIVF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas NIVF's P/E ratio is 0.55. In terms of profitability, EHC's ROE is +0.25%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, EHC is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for EHC.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
EHC vs MNDR Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, MNDR has a market cap of 53.6K. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while MNDR trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas MNDR's P/E ratio is -0.05. In terms of profitability, EHC's ROE is +0.25%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, EHC is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for EHC.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
EHC vs NIVFW Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, NIVFW has a market cap of 50K. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, EHC's ROE is +0.25%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, EHC is less volatile compared to NIVFW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check NIVFW's competition here
DocGo Inc. (NASDAQ: DCGOW)
EHC vs DCGOW Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas DCGOW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, EHC is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check DCGOW's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
EHC vs TLMDW Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas TLMDW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, EHC is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check TLMDW's competition here
Hanger, Inc. (NYSE: HNGR)
EHC vs HNGR Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas HNGR's P/E ratio is 19.71. In terms of profitability, EHC's ROE is +0.25%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, EHC is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for EHC.Check HNGR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
EHC vs ATIP-WT Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, EHC is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for EHC.Check ATIP-WT's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
EHC vs TVTY Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas TVTY's P/E ratio is 19.06. In terms of profitability, EHC's ROE is +0.25%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, EHC is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for EHC.Check TVTY's competition here
New Frontier Health Corporation (NYSE: NFH)
EHC vs NFH Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, NFH has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas NFH's P/E ratio is -19.75. In terms of profitability, EHC's ROE is +0.25%, compared to NFH's ROE of -0.06%. Regarding short-term risk, EHC is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for EHC.Check NFH's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
EHC vs SLHGP Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, EHC's ROE is +0.25%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, EHC is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for EHC.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
EHC vs SLHG Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas SLHG's P/E ratio is -1.48. In terms of profitability, EHC's ROE is +0.25%, compared to SLHG's ROE of N/A. Regarding short-term risk, EHC is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for EHC.Check SLHG's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
EHC vs DVCR Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas DVCR's P/E ratio is 28.34. In terms of profitability, EHC's ROE is +0.25%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, EHC is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for EHC.Check DVCR's competition here
Almost Family Inc. (NASDAQ: AFAM)
EHC vs AFAM Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas AFAM's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, EHC is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
EHC vs TLMD Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas TLMD's P/E ratio is -1.60. In terms of profitability, EHC's ROE is +0.25%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, EHC is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for EHC.Check TLMD's competition here
Kindred Healthcare, Inc. (NYSE: KND)
EHC vs KND Comparison July 2026
Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EHC stands at 11.2B. In comparison, KND has a market cap of 0. Regarding current trading prices, EHC is priced at $112.89 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EHC currently has a P/E ratio of 19.83, whereas KND's P/E ratio is -1.14. In terms of profitability, EHC's ROE is +0.25%, compared to KND's ROE of -0.53%. Regarding short-term risk, EHC is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for EHC.Check KND's competition here